Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591989 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)
A NA study, sponsored by Neurent Medical.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05591989 is a NA study that has completed, run by Neurent Medical. The registered enrollment target is 80 participants.
The verdict
NCT05591989, a NA study, has completed, sponsored by Neurent Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
Interventions
- DEVICE NEUROMARK System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2025-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05591989
The ClinicalTrials.gov registry entry for NCT05591989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neurent Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NEUROMARK System is the first listed.
NCT05591989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05591989 about?
NCT05591989 is a clinical study titled "Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)". The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
What is the current status of trial NCT05591989?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-26. Estimated completion is 2025-08-05.
What interventions are being tested in trial NCT05591989?
The interventions under investigation include: NEUROMARK System (DEVICE).
Who is sponsoring clinical trial NCT05591989?
This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.